Close Menu

NEW YORK — The US Food and Drug Administration last week reissued an Emergency Use Authorization for a PCR-based SARS-CoV-2 test from the Broad Institute to expand the types of samples it may use.

The agency also issued a new EUA for a SARS-CoV-2 immunoassay developed by Celltrion.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.